,outcome,arm 1,arm 2
0,intervention,"13 % of TLC D-99 patients, CHF",
0,Protocol-defined cardiotoxicity,"13 % of TLC D-99 patients, 2 cases",29 % of doxorubicin patients
0,"Protocol-defined cardiotoxicity, total study group",9 cases,9 cases
